EXECUTIVE SUMMARY
A survey of public funded research specifically targeting alternatives to animal testing was conducted over 2006/2007. Responses were received from 16 European countries (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany Hungary, Italy, Netherlands, Norway, Slovakia, Spain, Sweden, Switzerland and the United Kingdom). The responses were compiled by national agencies or national consensus platforms. The current annual total across the 16 countries was estimated as €30 million. The largest contributions came from the United Kingdom with €14.4 million (48% of the total) and Germany with €4.6 million (15% of the total). Also collated was information on the existence of a national strategy on alternatives research, the focus of any such strategies, the research priority setting process, stakeholder consultation in that process, project funding preferences or limits, coordination mechanisms and the separation of responsibilities of competent authorities (i.e., for research support, laboratory animal welfare and chemicals management). Countries with national strategies (France, Germany, the Netherlands, Sweden, Switzerland and the UK) are skewed towards the higher end of the spending distribution. These 6 countries account for over €25 million i.e., >80% of the overall total of national spending identified. Most countries have national consensus platforms. These should help to both stimulate stakeholder consultation and further national spending on alternatives research. The situation regarding the separation of responsibilities of competent authorities (i.e., for research support, laboratory animal welfare and chemicals management) is mixed. A degree of overlap exists in many cases. A research strategy that is receptive to and reflects regulatory developments -such as REACh with its marked resultant increase in animal use -is an obvious need that is as yet unmet in many of the countries surveyed. The need for a mechanism to collate details of active research projects within Europe as a whole was also identified.
INTRODUCTION
Directive 86/609, the animal experimentation directive states that EU Member States should encourage the development of new alternatives 1 . Over the last 20 years there has been an increasing interest in developing and validating alternative methods based on the concept of the 3Rs. A significant early stimulus to this was the campaign against testing cosmetics on animals and subsequently European legislation outlining a timetable for the prohibition of such testing was adopted. More recently, the new European chemical policy REACh 2 (Registration, Evaluation and Authorisation of Chemicals) has highlighted the urgent need for further progress in the development of alternatives in order to reduce the large projected animal use that will be a consequence of REACh 3 . One of the objectives of REACh is the 'promotion of alternative methods for assessment of hazards of substances'. Under REACh, the Commission must publish a report every 5 years on the funding of Alternative test methods, the first report is scheduled for the 1 June 2012.
The project was carried out under the aegis of the Eurogroup for Animals and ecopa with support from Procter & Gamble. It is hoped that the results of this survey will assist both the European Commission and Member States in better planning and cooperation in research in this area.
METHODOLOGY
In consultation with the European Commission (including ECVAM 4 , DG Research & DG Environment), Eurogroup for Animals, ecopa and representatives from industry, a questionnaire was drawn up in order to survey public funded research specifically targeting alternatives.
A broad range of questions were designed to establish the extent of government funding and also funding from other sources (e,g., European Commission, Industry and NGOs). Also collated was information on the existence of a national strategy on alternatives research, the focus of any such strategies, the research priority setting process, stakeholder consultation in that process, project funding preferences or limits, coordination mechanisms and the separation of responsibilities of competent authorities (i.e., for research support, laboratory animal welfare and chemicals management). It was determined that research into alternatives should not only include that involving in-vitro and non-animal procedures, but also research into refinement and reduction techniques. The questionnaire is presented in Annex 1.
Following receipt of the completed questionnaires, the responses were evaluated and summarised according to a set of harmonised responses that would facilitate statistical analysis (Annex 2). Each summary was then returned to the original respondents for confirmation. Tabulated responses and a summary have been compiled for each of the co-operating countries (see Section 4) . A breakdown and analysis of the overall results was also conducted (see Section 5).
SUMMARY OF COUNTRY RESPONSES
Responses were received from 16 countries, including those considered most likely to provide significant funding. A summary of the key points or observations for each country is provided below. The full responses for each country are provided in Annex 3.
Austria
Public supported alternatives research in Austria in 2006 is estimated at €200,000. The average for 1992 -2005 was reported as €250,000 per annum. The Federal ministries responsible for research support are the Ministry of Education, Science and Research, the Ministry for Health and Women, the Ministry for Economics and Labour and the Ministry for Agriculture, Forestry, Environment and Water. No other sources of funding were highlighted by the respondent. There is no existing national strategy in Austria with regards to coordination of research into 3R alternatives. Multi-stakeholder consultation takes place with regards to priority setting. There is no preference with regards to the magnitude of funding of the projects to be supported by public research support. No project funding limits are placed on the proportion of research that will be supported (i.e., up to 100%). There is a national consensus platform, ZET. There is partial overlap between the competent authorities for chemical management (i.e., the Federal Ministry of Agriculture, Forestry, Environment and Water) and those responsible for animal testing procedures (i.e., the Ministry of Education, Science and Research, the Ministry for Health and Women, the Ministry for Economics and Labour and the Ministry for Agriculture, Forestry, Environment and Water).
Respondent:
Wolf Frühauf (wolf.fruehauf@bmbwk.gv.at) National Platform:
ZET (Zentrum für Ersatz-und Ergänzungsmethoden zu Tierversuchen) Link:
http://www.zet.or.at
Belgium
No public funds specifically aimed at 3Rs research are available in Belgium. Recent financing of research on 3Rs was possible through Public Contract Research. The funding, as far as research on alternatives is concerned, is allocated upon a project basis and selected by the National Research Committee. The amount of funds released depends on the nature and "lifespan" of the project. In 2005, an amount of €400,000 was allocated to one project for duration of 3 years and in 2006 two projects were selected for a total amount of €116,000 for one year. This process of selection for projects will continue in 2007. In addition, some NGO's (such as BPAM 5 , APMA 6 etc.) occasionally promote research or application of alternative methods in research or education. Belgium has no general national strategy as such. Research on alternative methods is promoted through a public contract committee (the Public Contract Research) at the Federal Public Service Health, Food Chain Safety and Environment. Topics of projects may be selected through collaboration with local ethical committees of private, academic and public laboratories and the animal welfare officers in the laboratories. Replacement is the main focus of the research, but all three Rs are considered when public funds are made available. Once a project is underway cooperation and coordination between research groups is possible, although there is no particular cooperation with other stakeholders. The contracts for research are approved by a specific evaluation committee of the Public agency, namely the Federal Public Service Health, Food Chain Safety and Environment. The control of chemical management and control of animal testing procedures lies with two other distinct departments of the same Federal Public Service.
Respondent:
Jean Belot (Jean.Belot@health.fgov.be) National Platform:
http://www.fondation-prince-laurent.be
Czech Republic
Public supported research into alternatives In the Czech Republic was estimated at €2,000 in 2006. The Ministry of Health and Ministry of Education have responsibility for research support. No other sources of funds or funding were highlighted. There is currently no provision to match EU research support or indeed any indication of cooperation with other EU in this respect. There is a national strategy with regards to coordination of research into alternatives (although this is somewhat at odds with the estimate of public funded research into alternatives). This strategy is apparently focused on replacement. Priority setting is based on a consideration of societal and legislative needs and does entail an element of public consultation. There is no preference with regards to the magnitude of funding of the projects to be supported by public research support. No project funding limits are placed on the proportion of research that will be supported (i.e., up to 100%). There is a national consensus platform, Czecopa. The competent authority for chemical management is the same as that responsible for animal testing procedures (i.e., UKOZ, the Ministry of Agriculture). , €2 million from ANR 8 and €0.45 million from funds to support "Pôles de Compétitivité"). It appears that there is national strategy coordinated by the national platform (established in the form of a GIS or Groupement d'Intérêt Scientifique) that has an apparent focus on replacement. Project funding will vary depending on the project and other factors but can be up to 100% for the public sector, but lesser amounts for the private sector (i.e., 30%). The Ministries of Agriculture and Research has responsibility for animal testing procedures and the Health, Industry and Environment for chemical management.
Respondent

Respondent:
Bernard Andrieux (Bernard.andrieux@recherche.gouv.fr) 
Live Kleveland (live@dyrevernalliansen.org) National Platform:
To be established in 2007 Link:
http://oslovet.veths.no/fag.aspx?fag=56
Slovakia
Slovakia has allocated public funding of between €28,000 and €280,000 a year to the development of alternatives. There is no set amount and it obviously varies noticeably from year to year. 
Respondent:
Maria Dusinska (mdu@nilu.no) National Platform:
No national platform Link: -
Spain
There is no specific programme within the national agencies dedicated to funding research on alternative methods. Research projects specifically dedicated to alternatives are a minority. However, many research projects make use of alternative methods, and are thus financed by other rationale. The total expenditure on all general research is estimated at €4,000 million per year. An estimation of the total annual budget for in vitro alternatives is €500,000. . Each year from 2004 onwards the amount has been in the order of €1.6 million (15 million SEK). In addition, annually, about €100,000 comes from the Swedish Pharmaceutical industry and a similar sum from the Swedish Fund for Research to Animal Experiments. There is a national strategy and research has been focussed on all 3Rs. The intention is to bring about a decrease in the use of laboratory animals. The SAWA sets the priorities for this research and consults stakeholders through a scientific advisory committee. This committee is made up of experts in different biomedical fields, representatives from government agencies, animal welfare representatives and the pharmaceutical industry. Some projects have been jointly funded by both the Swedish government and the European Union. The amount of funding will vary depending on the project but can be as high as 100%. SAWA is responsible for research. Chemical management falls under the Swedish Chemical Inspectorate and control of animal testing procedures under the Swedish Medical Products Agency.
Respondent:
Hanna Augustsson (Hanna.Augustsson@djurskyddsmyndigheten.se) National Platform: Swecopa Link:
http://www.swecopa.se
Switzerland
Switzerland is not a member of the European Union. The amount allocated to the funding has remained consistent for the past two decades. Approximately €270,000 is specifically allocated to the development of alternative methods. Funding is also made available through other sources, mainly from industry and private foundations. This amount has also remained consistent in recent decades. All 3Rs are supported when funding allocation is decided, mostly with projects focusing on research and drug development. www.forschung3r.ch
United Kingdom
In the United Kingdom, the public funding of research into alternatives appears to be relatively significant as it is the Member State reporting the highest amount allocated. A total of €14.4 million, is available from a number of sources such as government institutes and departments and Research Councils including the NC3Rs 10 and BBSRC
11
. Funding is also provided through a number of other sources including industry, professional associations, private foundations and NGOs often in collaboration. The UK has a National Strategy which is set by the NC3Rs. It focuses on all 3Rs with allocation for projects dependent upon impact on the 3Rs and scientific quality. Both large and small projects are considered. Public funding providers usually allocate a total up to 80% of the amount requested, with the remainder expected to come from other sources. The NC3Rs also sets priorities. Stakeholders representing all relevant fields are consulted i.e., animal welfare, industry, academia and the government. Within the government there is no single specific Institute responsible for the allocation of funding. With regards to chemical management the Health and Safety Executive, the Environment Agency, Department of Environment and Rural Affairs and others all play a role. The Home Office is responsible for the animal testing procedures. The UK has an active platform which is represented through the Boyd Group.
Respondent:
mail@boyd-group.demon.co.uk National Platform:
Boyd Group Link:
www.boyd-group.demon.co.uk
RESULTS AND ANALYSIS
Country
There were responses from respondents in 16 countries i.e., Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany Hungary, Italy, Netherlands, Norway, Slovakia, Spain, Sweden, Switzerland and the United Kingdom.
Public Funded Alternatives Research
The total reported public funded research specifically targeting alternatives total across the 16 countries was approximately €30 million. It ranged from €0 in Italy to €14.4 million (equivalent to 49% of the total) in the United Kingdom (see Figures 1 & 2) 
12
. It is worthy noting that these figures relate specifically to research funds directly targeted at the 3Rs. It is highly likely that other research funds are being appliedalbeit indirectly -in other fields that are of benefit to the 3Rs. The responses relating to the provision of public funds for alternatives research can be categorised as follows; 
Reported Public Funds Targetted for 3Rs Research
Allocation (%)
4%
Mechanisms to Match EU Funding
The responses relating to the provision of public funds to match funding for alternatives research from EU (i.e., via Framework Programmes) can be categorised as follows; 
Not known/No responses
In nearly half the countries, respondents indicated that there was no systematic policy. In 12% of countries (i.e., Germany and the UK), there was a policy to avoid co-funding. In 19% of countries (i.e., Hungary, the Netherlands and Sweden), there was a policy to provided matched funding.
National Strategy for Alternatives Research
The responses detailing the existence of a national strategy to coordinate alternatives research are provided below;
No national strategy Existing national strategy
Not known/No responses
In 63% of the countries (i.e., Austria, Belgium, Czech Republic, Denmark, Finland, Hungary, Italy, Norway, Slovakia and Spain), respondents indicated that there was no national strategy. In 37% of the countries (i.e., France, Germany, the Netherlands, Sweden, Switzerland and the UK), the respondents reported the evolution or existence of a national strategy.
Focus of National Strategy
Of those countries for which the existence of a national strategy was reported, most respondents indicated that the strategy in each country (i.e., Germany, the Netherlands, Sweden, Switzerland and the UK) was based on all 3Rs. In France, there appears to be a focus on replacement. 
Priority Setting
When the respondents were asked about the process of research priority setting, 50% of the countries (i.e., Denmark, France, Germany, Netherlands, Norway, Sweden, Switzerland and the UK) indicated that this was coordinated at national level. No response or not known was the response of 38% of the respondents (i.e., Austria, Czech Republic, Finland, Hungary, Italy and Slovakia). In Begium priority setting is apparently set at institutional level, whilst the respondent from Spain indicated that there was no priority setting at all in that country. 
Stakeholder Consultation
The extent of stakeholder consultation in the research priority setting process indicated that partial consultation was to be found in 25% of countries (i.e., Belgium, Finland, Slovakia and Sweden) and full consultation was to be found in 50% of countries (i.e., Austria, Czech Republic, France, Germany, the Netherlands, Norway, Switzerland and the UK). No response or not known was forthcoming from 19% of respondents (i.e., Denmark, Hungary and Italy). Only for Spain did the respondent indicate that no stakeholder consultation took place in the research priority setting process. 
Yes (national platform exists) Not known/No responses
Separation of Responsibility between Competent Authorities
In the case of 44% of countries (i.e., Finland, France, Germany, the Netherlands, Norway, Sweden, the UK), the respondents indicated that the competent authorities for chemical management were separate from those responsible for animal welfare procedures. In the case of an additional 37% of countries (i.e., Austria, Belgium, Czech Republic, Slovakia, Spain and Switzerland) there was some degree of overlap in the responsibility of the competent authorities regarding these two responsibilities. In the remaining cases of Denmark, Hungary and Italy (20%), the respondents indicated not known or did not provide a response. 
SUMMARY & CONCLUSIONS
• A survey of public funded research specifically targeting alternatives was conducted. Responses were received from 16 European countries (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany Hungary, Italy, Netherlands, Norway, Slovakia, Spain, Sweden, Switzerland and the United Kingdom). The responses were compiled by national agencies or national consensus platforms.
• The current annual total across the 16 countries was estimated as €30 million and is comparable in magnitude with annual spending under FP programmes. FP6 provides a total of €80 million over five years to 13 projects that actively involve ECVAM • The largest contributions came from the United Kingdom with €14.4 million (48% of the total) and Germany with €4.6 million (15% of the total).
• Countries with national alternatives funding strategies (France, Germany, the Netherlands, Sweden Switzerland and the UK) are skewed towards the higher end of the spending distribution. These 6 countries account for €25 million i.e., >80% of the overall total of national spending identified..
• Where national strategies exist, they predominantly encompass all 3Rs (refinement, reduction and replacement) -rather than focus on replacement. It is unclear whether there is a consistent rationale based on an assumption that application of a 3R -as opposed to a 1R -approach is more likely to impact overall animal use.
• There is perhaps a missed opportunity to leverage EU funding. Most countries have no policy or a policy to avoid matched funding. This latter situation is apparently the case with both Germany and the UK. The two countries that devote most to national spending on alternatives (i.e., >60% of the reported total).
• Stakeholder consultation in research priority setting seems to be relatively common (if sometimes not always systematic or comprehensive).
• Most respondent countries already have or are in the process of establishing national consensus platforms (the exception is Slovakia). The platforms should help to stimulate stakeholder consultation, better research coordination and further national spending on alternatives research.
• The situation regarding the separation of responsibilities of competent authorities (i.e., for research support, laboratory animal welfare and chemicals management) is mixed. A degree of overlap exists in many cases. A research strategy that is receptive to and reflects regulatory developments -such as REACh with its marked resultant increase in animal use -is an obvious need that is as yet unmet in many of the countries surveyed.
• A system needs to be established whereby results and information generated, through the different projects funded in the Member States, are congregated and available to ensure alternatives are further developed or implemented where possible. A directory of active research projects would obviously be useful. Other Funds (%) n/a n/a n/a n/a n/a
Match EU Funds [4]
Cooperation other EU Fora [3] Existence of a National Strategy Government invites tenders for research projects into alternatives [1] 
Focus of Strategy
Expected project results should contribute to at least one of the three Rs.
[2]
Priority Setting
The three Rs. [ Other Funds (%) n/a n/a n/a n/a n/a
Match EU Funds
No [1] Cooperation other EU Fora No [1]
Existence of a National Strategy
Funds are focused on specific Topics planned for the Institution and year [1] 
Focus of Strategy
Predominately on Replacement (of the 3 Rs). Chemicals, cosmetics and medical devices. [4] 
Priority Setting
According to society and legislative needs [?]
Stakeholder Consultation
Yes via UKOZ (see below) [ Other Funds (%) n/a n/a n/a n/a varies n/a n/a n/a n/a Other Funds (%) n/a n/a n/a n/a n/a
Match EU Funds
No, BMBF tries to avoid double funding (in collaboration with ECVAM) [2] Cooperation other EU Fora [3] Existence of a National Strategy Yes -BMBF (www.fz-juelich.de/ptj/ foerderung) and ZEBET-Datenbank (www.dimdi.de/static/en/db/dbinfo /dbkurz/zt00.htm) [2] 
Focus of Strategy
All 3Rs. (11 projects: 6 x replacement, 3 x reduction und 2 x refinement). Also set: all 3Rs [ Other Funds (%) Yes n/a n/a n/a n/a Other Funds (%) n/a n/a n/a n/a n/a Other Funds (%) n/a n/a n/a n/a n/a Other Funds (%) n/a n/a n/a n/a n/a
Match EU Funds
Some projects have received EU money as well as Government funding [3] Cooperation other EU Fora [3] Existence of a National Strategy
Yes. Information on eligible projects published on website [2] 
Focus of Strategy
Research focused on all 3Rs. Intention to decrease the use of laboratory animals [2] 
Priority Setting
Priorities set by SAWA's scientific advisory committee for alternative methods [4] Stakeholder Consultation SAWA's scientific advisory committee for alternative methods [2] Project Magnitude Preference 
Stakeholder cooperation & coordination
Usually widespread and involves animal welfare, industry, academia and government [4] 
